- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 15, 2026 | 446.5M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 418.51K sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 322.87K sh |
| Capex | Q1 2026 · Mar 31, 2026 | $6.61M |
| Capex | Q1 2026 · Mar 31, 2025 | $6.21M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$72.07M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$103.69M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $116.94M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $133.9M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $196.51M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $163.08M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $171.67M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $721.75M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $698.58M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $767.87M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $710.41M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $129.42M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $138.36M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $203.91M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $214.59M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $466.5M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $442.69M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $925.67M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $913.17M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.19 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.36 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.19 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.36 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $38.95M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $43.8M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $62.49M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $75.97M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$79.05M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$116.16M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$81.04M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$121.22M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $42.5M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $42.72M |
| Revenue | Q1 2026 · Mar 31, 2026 | $71.43M |
| Revenue | Q1 2026 · Mar 31, 2025 | $49.32M |